Diligent helps Sponsors and CROs with over 200 RFIs completed by clinical trial service providers across 13 service areas

August 27, 2021

Diligent has saved time and costs for Clinical Trial Sponsors and CROs with the delivery of over 200 completed RFIs (Requests for Information) from Providers of clinical trial services.

By the end of 2021 Diligent will also have completed around 50 Vendor Qualification Assessments (VQAs) for Diligent subscribers.

Sponsors and CROs use the Diligent Qualification Platform to find new suppliers for a wide range of services. In the past year, Diligent delivered over 200 completed Requests for Information (RFIs) across 13 different service categories:

    • Bioanalytical Labs
    • Biomarker Labs
    • Biostatistics
    • Central Labs
    • COA
    • CRO Clinical Monitoring
    • CRO Medical Writing
    • IxRS
    • CRO Data Management
    • Mobile HCP Visits
    • Telemedicine
    • eConsent
    • Medical Imaging

Which services are most in demand for clinical trial sponsors?

Top services searched in the last year are Data Management Services, Biostatistics, Bioanalytical and Biomarker Laboratories, plus Clinical Monitoring Services.

One strength of the Diligent Qualification Platform is the wide range of service areas covered, including newer markets like eClinical and mobile technologies. Not surprisingly, since the 2020 COVID-19 lockdowns we saw an increased interest in Mobile HCP Visits and Telemedicine.

The full range of standards in the Diligent Platform are shown below, including the latest categories to be added this year, Patient Recruitment & Retention and Mobile Cardiac Monitoring.

Clinical trial services covered by Diligent

Sponsors can use the platform for standardized RFI data – as well as anonymized and completed Vendor Qualification Assessments (VQAs) – against the industry-agreed standards in the Diligent Platform for any of these categories.

To join the growing community of clinical trial sponsors and service providers using Diligent to accelerate vendor qualification processes, please contact George Parrish at accelerate@diligentpharma.com

The Diligent platform will simplify and streamline your provider selection and qualification processes